PANRETIN

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 59212-601
  • Package NDC 59212-601-22
  • Application number NDA020886
  • SPL ID 5b7465cd-3367-44ee-a11d-d021d6400a23
  • SPL set ID 49c16717-7d86-4257-80c9-baa1417e5555
  • UNII 1UA8E65KDZ
  • RxCUI 213502
  • RxCUI 313847

What the source publishes

Labeler
Advanz Pharma (US) Corp.
Active ingredients
alitretinoin
Form
GEL
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:59212-601_5b7465cd-3367-44ee-a11d-d021d6400a23
{
  "name": "PANRETIN",
  "splId": "5b7465cd-3367-44ee-a11d-d021d6400a23",
  "labels": [
    {
      "setId": "49c16717-7d86-4257-80c9-baa1417e5555",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49c16717-7d86-4257-80c9-baa1417e5555",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49c16717-7d86-4257-80c9-baa1417e5555"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "Advanz Pharma (US) Corp.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 g in 1 TUBE (59212-601-22)",
      "package_ndc": "59212-601-22",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190910"
    }
  ],
  "productId": "59212-601_5b7465cd-3367-44ee-a11d-d021d6400a23",
  "useDomain": "unknown",
  "dosageForm": "GEL",
  "productNdc": "59212-601",
  "deaSchedule": null,
  "genericName": "alitretinoin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ALITRETINOIN",
      "strength": "60 mg/60g"
    }
  ],
  "applicationNumber": "NDA020886",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190910",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175607",
      "M0018962"
    ],
    "upc": [
      "0359212601223"
    ],
    "unii": [
      "1UA8E65KDZ"
    ],
    "rxcui": [
      "213502",
      "313847"
    ],
    "spl_set_id": [
      "49c16717-7d86-4257-80c9-baa1417e5555"
    ],
    "pharm_class_cs": [
      "Retinoids [CS]"
    ],
    "pharm_class_epc": [
      "Retinoid [EPC]"
    ],
    "manufacturer_name": [
      "Advanz Pharma (US) Corp."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:59212-601_5b7465cd-3367-44ee-a11d-d021d6400a23"